Adient Plc · NYSE:ADNT
Adient — J.P. Morgan Auto Conference 2026
9 slides from Adient's conference presentation, Aug 13, 2026
Slide 1: J.P. Morgan Auto Conference 2026
J.P. Morgan Auto Conference 2026 August 13, 2026 Adient – PUBLIC
Slide 2: Important Information
Important Information Adient has made statements in this document that are forward-looking and, therefore, are subject to risks and uncertainties. All statements in this document other than statements of historical fact are statements that are, or could be, deemed “forward-looking statements” within
Slide 3: Agenda
Agenda > Business Update Mark Oswald Executive VP and CFO Jim Conklin Executive VP Americas > Q&A J.P. Morgan Auto Conference 2026 Adient – PUBLIC 3
Slide 4: Resilient FY26 execution builds momentum into FY27
Resilient FY26 execution builds momentum into FY27 FY26: DELIVERING COMMITMENTS FY27: ENTERING WITH STRENGTH Growth over market Program wins and launches drive growth Program execution and customer wins Growth over market expected to continue driving strong growth in key regions Strong business perf
Slide 5: Executing Today, Investing for Profitable Growth Tomorrow
AMERICAS Operational execution – Delivering through volatility Executing Today, Sales growth and margin expansion despite temporary headwinds Investing for Profitable Americas Q3 Adj.-EBITDA increased $13M y-o-y to $125M Execution discipline across launches, quality, cost management, and flexibility
Slide 6: Q&A
SAASSAOSASASAAASASASAASAASAASAAASASAASASAASASASASASAAAGASAASGAASAAASAS ASA ASSS Q&A SAIASSAOSASAASAASAASASASAAASAASASASAASAASAASAASAAGASAASASAGSAAGASAASASAS AAAS
Slide 7: Appendix and Financial Reconciliations
Appendix and Financial Reconciliations FY26 Third Quarter Adient – PUBLIC
Slide 8: Non-GAAP reconciliations – Adj.-EBITDA
Non-GAAP reconciliations – Adj.-EBITDA J.P. Morgan Auto Conference 2026 Adient – PUBLIC August 13, 2026 8
Slide 9: Segment performance
Segment performance Q1 2025 Q1 2026 Corporate/ Corporate/ Americas EMEA Asia Consolidated Americas EMEA Asia Consolidated Eliminations Eliminations Net Sales 1,611 1,129 772 (17) 3,495 1,642 1,205 819 (22) 3,644 Adjusted EBITDA 85 22 111 (22) 196 80 34 115 (22) 207 Adjusted Equity Income - 5 16 - 21